RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
$3.16
-0.02 (-0.63%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-25.65%
1Y
-39.46%
YTD
-24.76%
Open$3.10
Previous Close$3.18
Day High$3.27
Day Low$3.09
52W High$7.18
52W Low$2.77
Volume—
Avg Volume19.83M
Market Cap1.71B
P/E Ratio—
EPS$-1.20
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$4.31
Below
SMA 200
$4.89
Below
RSI (14)
34.7
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
14 analysts
Price Target
+814.6% upside
Current
$3.16
$3.16
Target
$28.90
$28.90
$21.05
$28.90 avg
$39.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 89.41M | 72.52M | 309.68M |
| Net Income | -771,998,593 | -563,502,622 | -18,426,824 |
| Profit Margin | -863.4% | -820.2% | -6.0% |
| EBITDA | -727,425,183 | -560,465,469 | -21,116,374 |
| Free Cash Flow | — | — | -13,211,156 |
| Rev Growth | +23.3% | +23.3% | +0.8% |
| Debt/Equity | 0.02 | 0.02 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |